Skip to main content
Erschienen in: Surgical Endoscopy 6/2015

01.06.2015

Endoscopic ultrasound-guided fine-needle biopsy of small solid pancreatic lesions using a 22-gauge needle with side fenestration

verfasst von: Carlo Fabbri, Carmelo Luigiano, Antonella Maimone, Ilaria Tarantino, Paola Baccarini, Adele Fornelli, Rosa Liotta, Annamaria Polifemo, Luca Barresi, Mario Traina, Clara Virgilio, Vincenzo Cennamo

Erschienen in: Surgical Endoscopy | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Early detection of small pancreatic cancer is important because expected survival is markedly better for tumors ≤2 cm. A new endoscopic ultrasound-(EUS) guided biopsy needle with side fenestration has been recently developed to enable fine-needle biopsy (FNB) under EUS guidance. The aim of this study was to evaluate the outcome of EUS–FNB using a 22-gauge ProCore needle in solid pancreatic lesions ≤2 cm, in terms of diagnostic accuracy and yield.

Methods

From January 2011 to December 2012, all consecutive EUS-guided tissue sampling of small pancreatic lesions (≤2 cm) were performed using 22-gauge ProCore needles; the data of these patients were analyzed retrospectively.

Results

Sixty-eight patients with a mean age of 65.7 years were included. The mean lesion size was 16.5 mm (range 5–20). None of the patients developed complications. On pathological examination, the tissue retrieved was judged adequate in 58 out of 68 cases (85.3 %) and the presence of a tissue core was recorded in 36 out of 68 cases (52.9 %). The overall sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 80, 100, 100, 40, and 82 %, respectively.

Conclusion

Our results suggested that EUS–FNB of small pancreatic lesions using a 22-gauge ProCore needle is effective and safe, and supports our hypothesis that EUS–FNB is highly useful in establishing the nature of small pancreatic lesions.
Literatur
1.
Zurück zum Zitat Schnelldorfer T, Ware AL, Sarr MG et al (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247:456–462CrossRefPubMed Schnelldorfer T, Ware AL, Sarr MG et al (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247:456–462CrossRefPubMed
2.
3.
Zurück zum Zitat Cleary SP, Gryfe R, Guindi M et al (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198:722–731CrossRefPubMed Cleary SP, Gryfe R, Guindi M et al (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198:722–731CrossRefPubMed
4.
Zurück zum Zitat Benassai G, Mastrorilli M, Quarto G et al (2000) Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73:212–218CrossRefPubMed Benassai G, Mastrorilli M, Quarto G et al (2000) Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73:212–218CrossRefPubMed
5.
Zurück zum Zitat Ahmad NA, Kochman ML, Lewis JD et al (2001) Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma. J Clin Gastroenterol 32:54–58CrossRefPubMed Ahmad NA, Kochman ML, Lewis JD et al (2001) Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma. J Clin Gastroenterol 32:54–58CrossRefPubMed
6.
Zurück zum Zitat DeWitt J, Devereaux B, Chriswell M et al (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141:753–763CrossRefPubMed DeWitt J, Devereaux B, Chriswell M et al (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141:753–763CrossRefPubMed
7.
Zurück zum Zitat Sahai AV, Schembre D, Stevens PD et al (1999) A multicenter U.S. experience with EUS-guided fine-needle aspiration using the Olympus GF-UM30P echoendoscope: safety and effectiveness. Gastrointest Endosc 50:792–796CrossRefPubMed Sahai AV, Schembre D, Stevens PD et al (1999) A multicenter U.S. experience with EUS-guided fine-needle aspiration using the Olympus GF-UM30P echoendoscope: safety and effectiveness. Gastrointest Endosc 50:792–796CrossRefPubMed
8.
Zurück zum Zitat Ylagan LR, Edmundowicz S, Kasal K, Walsh D, Lu DW (2002) Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer 96:362–369CrossRefPubMed Ylagan LR, Edmundowicz S, Kasal K, Walsh D, Lu DW (2002) Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer 96:362–369CrossRefPubMed
9.
Zurück zum Zitat Siddiqui AA, Brown LJ, Hong SK et al (2011) Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasound-guided fine needle aspiration. Dig Dis Sci 56:3370–3375CrossRefPubMed Siddiqui AA, Brown LJ, Hong SK et al (2011) Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasound-guided fine needle aspiration. Dig Dis Sci 56:3370–3375CrossRefPubMed
10.
Zurück zum Zitat Iglesias-Garcia J, Poley JW, Larghi A et al (2011) Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc 73:1189–1196CrossRefPubMed Iglesias-Garcia J, Poley JW, Larghi A et al (2011) Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc 73:1189–1196CrossRefPubMed
11.
Zurück zum Zitat Larghi A, Iglesias-Garcia J, Poley JW et al (2013) Feasibility and yield of a novel 22-gauge histology EUS needle in patients with pancreatic masses: a multicenter prospective cohort study. Surg Endosc 27:3733–3738CrossRefPubMed Larghi A, Iglesias-Garcia J, Poley JW et al (2013) Feasibility and yield of a novel 22-gauge histology EUS needle in patients with pancreatic masses: a multicenter prospective cohort study. Surg Endosc 27:3733–3738CrossRefPubMed
12.
Zurück zum Zitat Iwashita T, Nakai Y, Samarasena JB et al (2013) High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions. Gastrointest Endosc 77:909–915CrossRefPubMed Iwashita T, Nakai Y, Samarasena JB et al (2013) High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions. Gastrointest Endosc 77:909–915CrossRefPubMed
13.
Zurück zum Zitat Canto MI, Harinck F, Hruban RH et al (2013) International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62:339–347CrossRefPubMedCentralPubMed Canto MI, Harinck F, Hruban RH et al (2013) International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62:339–347CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Chen J, Yang R, Lu Y et al (2012) Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. J Cancer Res Clin Oncol 138:1433–1441CrossRefPubMed Chen J, Yang R, Lu Y et al (2012) Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. J Cancer Res Clin Oncol 138:1433–1441CrossRefPubMed
15.
Zurück zum Zitat Haba S, Yamao K, Bhatia V et al (2013) Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol 48:973–981CrossRefPubMed Haba S, Yamao K, Bhatia V et al (2013) Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol 48:973–981CrossRefPubMed
16.
Zurück zum Zitat Wiersema MJ, Vilmann P, Giovannini M et al (1997) Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 112:1087–1095CrossRefPubMed Wiersema MJ, Vilmann P, Giovannini M et al (1997) Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 112:1087–1095CrossRefPubMed
17.
Zurück zum Zitat Tadic M, Kujundzic M, Stoos-Veic T et al (2008) Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings. Dig Dis 26:377–382CrossRefPubMed Tadic M, Kujundzic M, Stoos-Veic T et al (2008) Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings. Dig Dis 26:377–382CrossRefPubMed
18.
Zurück zum Zitat Katanuma A, Maguchi H, Yane K et al (2013) Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci 58:2093–2099CrossRefPubMedCentralPubMed Katanuma A, Maguchi H, Yane K et al (2013) Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci 58:2093–2099CrossRefPubMedCentralPubMed
Metadaten
Titel
Endoscopic ultrasound-guided fine-needle biopsy of small solid pancreatic lesions using a 22-gauge needle with side fenestration
verfasst von
Carlo Fabbri
Carmelo Luigiano
Antonella Maimone
Ilaria Tarantino
Paola Baccarini
Adele Fornelli
Rosa Liotta
Annamaria Polifemo
Luca Barresi
Mario Traina
Clara Virgilio
Vincenzo Cennamo
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 6/2015
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-014-3846-6

Weitere Artikel der Ausgabe 6/2015

Surgical Endoscopy 6/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.